These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38523249)

  • 21. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
    Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
    Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two siblings with a rare type of maturity-onset diabetes of the young (MODY).
    Alhakim FR; AlKhayyat H
    BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36764736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RD Lawrence lecture 2012: assessing aetiology in diabetes: how C-peptide, CRP and fucosylation came to the party!
    Owen KR
    Diabet Med; 2013 Mar; 30(3):260-6. PubMed ID: 23106207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Importance of Molecular Genetic Testing for Precision Diagnostics, Management, and Genetic Counseling in MODY Patients.
    Butnariu LI; Bizim DA; Oltean C; Rusu C; Pânzaru MC; Păduraru G; Gimiga N; Ghiga G; Moisă ȘM; Țarcă E; Starcea IM; Popa S; Trandafir LM
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
    Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
    Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new screening strategy and whole-exome sequencing for the early diagnosis of maturity-onset diabetes of the young.
    Liu Y; Xie Z; Sun X; Wang Y; Xiao Y; Luo S; Huang G; Li X; Xia Y; Zhou Z
    Diabetes Metab Res Rev; 2021 Jul; 37(5):e3381. PubMed ID: 32621647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
    Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
    Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.
    Shields BM; McDonald TJ; Ellard S; Campbell MJ; Hyde C; Hattersley AT
    Diabetologia; 2012 May; 55(5):1265-72. PubMed ID: 22218698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
    Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Frequency of Recessive WFS1 Mutations Among Indian Children With Islet Antibody-negative Type 1 Diabetes.
    Menon JC; Singh P; Archana A; Singh P; Mittal M; Kanga U; Mandal K; Seth A; Bhatia V; Dabadghao P; Sudhanshu S; Garg A; Vishwakarma R; Sarangi AN; Verma S; Singh SK; Bhatia E
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1072-e1082. PubMed ID: 37931151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the frequency and clinical features of maturity-onset diabetes in the young in the pediatric and adolescent diabetes population in Iran.
    Zamanfar D; Ferdosipour F; Ebrahimi P; Moghadam M; Amoli MM; Asadi M; Monajati M
    J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1240-1249. PubMed ID: 36100423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.
    Besser RE; Shields BM; Hammersley SE; Colclough K; McDonald TJ; Gray Z; Heywood JJ; Barrett TG; Hattersley AT
    Pediatr Diabetes; 2013 May; 14(3):181-8. PubMed ID: 23289766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes.
    McDonald TJ; Colclough K; Brown R; Shields B; Shepherd M; Bingley P; Williams A; Hattersley AT; Ellard S
    Diabet Med; 2011 Sep; 28(9):1028-33. PubMed ID: 21395678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes.
    Rubio-Cabezas O; Edghill EL; Argente J; Hattersley AT
    Diabet Med; 2009 Oct; 26(10):1070-4. PubMed ID: 19900242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monogenic Diabetes: Genetics and Relevance on Diabetes Mellitus Personalized Medicine.
    Sousa M; Bruges-Armas J
    Curr Diabetes Rev; 2020; 16(8):807-819. PubMed ID: 31886753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monogenic diabetes: implications for therapy of rare types of disease.
    Malecki MT; Mlynarski W
    Diabetes Obes Metab; 2008 Aug; 10(8):607-16. PubMed ID: 17488343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
    Tatsi EB; Kanaka-Gantenbein C; Scorilas A; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2020 Feb; 21(1):28-39. PubMed ID: 31604004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maturity onset diabetes of the young: clinical characteristics, diagnosis and management.
    Kavvoura FK; Owen KR
    Pediatr Endocrinol Rev; 2012 Dec-2013 Jan; 10(2):234-42. PubMed ID: 23539835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register.
    Harsunen M; Kettunen JLT; Härkönen T; Dwivedi O; Lehtovirta M; Vähäsalo P; Veijola R; Ilonen J; Miettinen PJ; Knip M; Tuomi T
    Diabetologia; 2023 Mar; 66(3):438-449. PubMed ID: 36418577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.